We are live on ! Find out more
6CM

683 Capital Management Portfolio holdings

AUM $1.92B
1-Year Est. Return 85.52%
This Fund
S&P 500
This Quarter Est. Return
+13.04%
1 Year Est. Return
+85.52%
3 Year Est. Return
+282.16%
5 Year Est. Return
+254.87%
10 Year Est. Return
+3,288.81%
AUM
$1.18B
AUM Growth
-$112M
Cap. Flow
-$159M
Cap. Flow %
-13.49%
Top 10 Hldgs %
34.43%
Holding
372
New
125
Increased
6
Reduced
44
Closed
64

Top Buys

Rank Stock Value
1
MBC icon
MasterBrand
MBC
+$33.6M
2
NE icon
Noble Corp
NE
+$30.1M
3
COF icon
Capital One
COF
+$17.7M
4
LEN.B icon
Lennar Class B
LEN.B
+$15.2M
5
APLS
Apellis Pharmaceuticals
APLS
+$9.28M

Top Sells

Rank Stock Value
1
LEN icon
Lennar Class A
LEN
+$41.7M
2
OPEN icon
Opendoor
OPEN
+$27M
3
ENVA icon
Enova International
ENVA
+$22.8M
4
PPLI
People Inc
PPLI
+$20.2M
5
CND
Concord Acquisition Corp.
CND
+$15.6M

Sector Composition

Rank Sector Weight
1 Financials 33.32%
2 Healthcare 19.05%
3 Consumer Discretionary 8.98%
4 Energy 6.58%
5 Materials 6.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABOS icon
201
Acumen Pharmaceuticals
ABOS
$162M
$169K 0.01%
+31,246
New +$210K
LMNR icon
202
Limoneira
LMNR
$249M
$169K 0.01%
+13,813
New +$177K
RGF
203
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$169K 0.01%
+2,118
New +$173K
HQI icon
204
HireQuest
HQI
$179M
$167K 0.01%
+10,535
New +$167K
EEX
205
DELISTED
Emerald Holding
EEX
$167K 0.01%
+47,050
New +$169K
CLPT icon
206
ClearPoint Neuro
CLPT
$395M
$164K 0.01%
+19,362
New +$184K
BYRN icon
207
Byrna Technologies
BYRN
$106M
$161K 0.01%
+20,567
New +$154K
IMMR icon
208
Immersion
IMMR
$255M
$161K 0.01%
+22,902
New +$147K
HBB icon
209
Hamilton Beach Brands
HBB
$323M
$158K 0.01%
+12,724
New +$164K
OMGA
210
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$156K 0.01%
+27,301
New +$153K
PBYI icon
211
Puma Biotechnology
PBYI
$407M
$154K 0.01%
+36,500
New +$126K
BCAB icon
212
BioAtla
BCAB
$5.53M
$153K 0.01%
+372
New +$154K
LCTX icon
213
Lineage Cell Therapeutics
LCTX
$284M
$151K 0.01%
+128,840
New +$162K
BKSY icon
214
BlackSky Technology
BKSY
$1.03B
$151K 0.01%
+12,225
New +$163K
GTHX
215
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$148K 0.01%
+27,292
New +$229K
VOXX
216
DELISTED
VOXX International Corporation Class A
VOXX
$147K 0.01%
+17,541
New +$159K
EVLO
217
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$145K 0.01%
+4,515
New +$179K
TRDA icon
218
Entrada Therapeutics
TRDA
$274M
$140K 0.01%
+10,355
New +$182K
IGICW
219
DELISTED
International General Insurance Holdings Ltd. Warrants expiring 03/17/2025
IGICW
$133K 0.01%
228,698
-219,702
-49% -$139K
KULR icon
220
KULR Technology Group
KULR
$127M
$127K 0.01%
+13,276
New +$164K
BIVI icon
221
BioVie
BIVI
$15.4M
$125K 0.01%
+161
New +$87K
LTRX icon
222
Lantronix
LTRX
$263M
$122K 0.01%
+28,183
New +$133K
NUVB.WS
223
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$121K 0.01%
835,323
– –
ANGI icon
224
Angi Inc
ANGI
$194M
$118K 0.01%
5,000
-137,030
-96% -$3.07M
BHACW
225
DELISTED
Focus Impact BH3 Acquisition Company Warrants
BHACW
$117K 0.01%
990,000
– –
7 8
9
10 11

Similar funds

QOP
Quinn Opportunity Partners Charlottesville, Virginia $1.92B AUM 31.26% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $1.91B AUM 24.37% 1-Year Est. Return
MC
Maren Capital Chicago, Illinois $1.91B AUM 17.37% 1-Year Est. Return
RCAG
Rehmann Capital Advisory Group Lansing, Michigan $1.92B AUM 16.97% 1-Year Est. Return
BOH
Bank of Hawaii Honolulu, Hawaii $1.91B AUM 22.08% 1-Year Est. Return
DCM
Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return
CC
Clearline Capital New York $1.93B AUM 38.13% 1-Year Est. Return
IAN
Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

683 Capital Management's Q4 2022 Portfolio in Review

As of Q4 2022, 683 Capital Management held 372 positions worth $1.18B, down 8.7% from $1.29B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

683 Capital Management withdrew a net $159M in Q4 2022, closing 64 positions and reducing 44 holdings. Its most notable exit was Lennar Class A, an estimated $41.7M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, 683 Capital Management opened a new position in MasterBrand worth $31M.

  • 683 Capital Management's largest Q4 2022 buy was MasterBrand: 4,100,000 shares worth $31M.
  • 683 Capital Management added most to Capital One in Q4 2022, an estimated $17.7M increase.
  • 683 Capital Management's biggest Q4 2022 reduction was Enova International, cutting an estimated $22.8M.
  • 683 Capital Management fully exited Lennar Class A in Q4 2022, selling an estimated $41.7M.
  • 683 Capital Management's ten largest holdings make up 34% of its $1.18B portfolio in Q4 2022.
  • 683 Capital Management opened 125 new positions and closed 64 in Q4 2022.
  • 683 Capital Management's portfolio value fell 8.7% quarter-over-quarter to $1.18B.

Based on 683 Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.